Cargando…

Extraction, Purification, and Elucidation of Six Ginkgol Homologs from Ginkgo biloba Sarcotesta and Evaluation of Their Anticancer Activities

Ginkgols are active constituents from Ginkgo biloba L. (GB) and have pharmacological activities, such as antibacterial and antioxidant activities. In our previous report, only five ginkgols were separated. However, ginkgol C17:1 had two isomers, for which their separation, identification, and bioact...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Fengnan, Boateng, Isaac Duah, Yang, Xiaoming, Li, Yuanyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699512/
https://www.ncbi.nlm.nih.gov/pubmed/36431878
http://dx.doi.org/10.3390/molecules27227777
_version_ 1784839092133953536
author Li, Fengnan
Boateng, Isaac Duah
Yang, Xiaoming
Li, Yuanyuan
author_facet Li, Fengnan
Boateng, Isaac Duah
Yang, Xiaoming
Li, Yuanyuan
author_sort Li, Fengnan
collection PubMed
description Ginkgols are active constituents from Ginkgo biloba L. (GB) and have pharmacological activities, such as antibacterial and antioxidant activities. In our previous report, only five ginkgols were separated. However, ginkgol C17:1 had two isomers, for which their separation, identification, and bioactivities have not yet been investigated. Hence, this research reports the successful isolation of six ginkgol homologs with alkyl substituents—C17:1-Δ(12), C15:1-Δ(8), C13:0, C17:2, C17:1-Δ(10), and C15:0—for the first time using HPLC. This was followed by the identification of their chemical structures using Fourier transform infrared (FTIR), ultraviolet (UV), gas chromatography and mass spectrometry (GC-MS), carbon-13 nuclear magnetic resonance ((13)C-NMR), and proton nuclear magnetic resonance ((1)H-NMR) analysis. The results showed that two ginkgol isomers, C17:1-Δ(12) and C17:1-Δ(10), were obtained simultaneously from the ginkgol C17:1 mixture and identified entirely for the first time. That aside, the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) assay showed that the six ginkgol homologs possessed significant antiproliferation effects against HGC and HepG2 cells. Furthermore, the ginkgols with unsaturated side chains (C17:2, C15:1-Δ(8), C17:1-Δ(12), and C17:1-Δ(10)) exhibited more potent inhibitory effects than ginkgols with saturated side chains (C13:0, C15:0). In addition, unsaturated ginkgol C15:1-Δ(8) showed the most potent cytotoxicity on HepG2 and HGC cells, of which the half-maximal inhibition concentrations (IC(50)) were 18.84 ± 2.58 and 13.15 ± 2.91 μM, respectively. The IC(50) for HepG2 and HGC cells for the three unsaturated ginkgols (C17:1-Δ(10), C17:2 and C17:1-Δ(12)) were ~59.97, ~60.82, and ~68.97 μM for HepG2 and ~30.97, ~33.81, and ~34.55 μM for HGC cells, respectively. Comparing the ginkgols’ structure–activity relations, the findings revealed that the position and number of the double bonds of the ginkgols with 17 side chain carbons in length had no significant difference in anticancer activity.
format Online
Article
Text
id pubmed-9699512
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96995122022-11-26 Extraction, Purification, and Elucidation of Six Ginkgol Homologs from Ginkgo biloba Sarcotesta and Evaluation of Their Anticancer Activities Li, Fengnan Boateng, Isaac Duah Yang, Xiaoming Li, Yuanyuan Molecules Article Ginkgols are active constituents from Ginkgo biloba L. (GB) and have pharmacological activities, such as antibacterial and antioxidant activities. In our previous report, only five ginkgols were separated. However, ginkgol C17:1 had two isomers, for which their separation, identification, and bioactivities have not yet been investigated. Hence, this research reports the successful isolation of six ginkgol homologs with alkyl substituents—C17:1-Δ(12), C15:1-Δ(8), C13:0, C17:2, C17:1-Δ(10), and C15:0—for the first time using HPLC. This was followed by the identification of their chemical structures using Fourier transform infrared (FTIR), ultraviolet (UV), gas chromatography and mass spectrometry (GC-MS), carbon-13 nuclear magnetic resonance ((13)C-NMR), and proton nuclear magnetic resonance ((1)H-NMR) analysis. The results showed that two ginkgol isomers, C17:1-Δ(12) and C17:1-Δ(10), were obtained simultaneously from the ginkgol C17:1 mixture and identified entirely for the first time. That aside, the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) assay showed that the six ginkgol homologs possessed significant antiproliferation effects against HGC and HepG2 cells. Furthermore, the ginkgols with unsaturated side chains (C17:2, C15:1-Δ(8), C17:1-Δ(12), and C17:1-Δ(10)) exhibited more potent inhibitory effects than ginkgols with saturated side chains (C13:0, C15:0). In addition, unsaturated ginkgol C15:1-Δ(8) showed the most potent cytotoxicity on HepG2 and HGC cells, of which the half-maximal inhibition concentrations (IC(50)) were 18.84 ± 2.58 and 13.15 ± 2.91 μM, respectively. The IC(50) for HepG2 and HGC cells for the three unsaturated ginkgols (C17:1-Δ(10), C17:2 and C17:1-Δ(12)) were ~59.97, ~60.82, and ~68.97 μM for HepG2 and ~30.97, ~33.81, and ~34.55 μM for HGC cells, respectively. Comparing the ginkgols’ structure–activity relations, the findings revealed that the position and number of the double bonds of the ginkgols with 17 side chain carbons in length had no significant difference in anticancer activity. MDPI 2022-11-11 /pmc/articles/PMC9699512/ /pubmed/36431878 http://dx.doi.org/10.3390/molecules27227777 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Li, Fengnan
Boateng, Isaac Duah
Yang, Xiaoming
Li, Yuanyuan
Extraction, Purification, and Elucidation of Six Ginkgol Homologs from Ginkgo biloba Sarcotesta and Evaluation of Their Anticancer Activities
title Extraction, Purification, and Elucidation of Six Ginkgol Homologs from Ginkgo biloba Sarcotesta and Evaluation of Their Anticancer Activities
title_full Extraction, Purification, and Elucidation of Six Ginkgol Homologs from Ginkgo biloba Sarcotesta and Evaluation of Their Anticancer Activities
title_fullStr Extraction, Purification, and Elucidation of Six Ginkgol Homologs from Ginkgo biloba Sarcotesta and Evaluation of Their Anticancer Activities
title_full_unstemmed Extraction, Purification, and Elucidation of Six Ginkgol Homologs from Ginkgo biloba Sarcotesta and Evaluation of Their Anticancer Activities
title_short Extraction, Purification, and Elucidation of Six Ginkgol Homologs from Ginkgo biloba Sarcotesta and Evaluation of Their Anticancer Activities
title_sort extraction, purification, and elucidation of six ginkgol homologs from ginkgo biloba sarcotesta and evaluation of their anticancer activities
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699512/
https://www.ncbi.nlm.nih.gov/pubmed/36431878
http://dx.doi.org/10.3390/molecules27227777
work_keys_str_mv AT lifengnan extractionpurificationandelucidationofsixginkgolhomologsfromginkgobilobasarcotestaandevaluationoftheiranticanceractivities
AT boatengisaacduah extractionpurificationandelucidationofsixginkgolhomologsfromginkgobilobasarcotestaandevaluationoftheiranticanceractivities
AT yangxiaoming extractionpurificationandelucidationofsixginkgolhomologsfromginkgobilobasarcotestaandevaluationoftheiranticanceractivities
AT liyuanyuan extractionpurificationandelucidationofsixginkgolhomologsfromginkgobilobasarcotestaandevaluationoftheiranticanceractivities